Oncopeptides

Website: Oncopeptides
Business Area(s): 


Description: 

Oncopeptides is a pharmaceutical company developing drugs for the treatment of cancer. The company is focusing on the development of the lead product candidate melflufen (Ygalo®), an alkylating peptide, belonging to a new class of drugs called Peptidase Enhanced Compounds. 

Location(s): 
Stockholm
Sweden